TY - JOUR
T1 - Dose-response effect of serum butyrylcholinesterase activity after clinical doses of pancuronium
AU - Motamed, C.
AU - Fanen, P.
AU - Feiss, P.
AU - Kirov, K.
AU - Duvaldestin, P.
PY - 2008/11/1
Y1 - 2008/11/1
N2 - Introduction: Low-dose pancuronium is known to affect serum cholinesterase activity (BChE); however, the dose-response effect of clinical doses of pancuronium on BChE has not been investigated. Methods: Thirteen ASA I-II patients scheduled for elective surgery requiring muscle relaxation were enrolled in this study. All patients had normal BChE before surgery. Incremental doses of pancuronium (10, 20, 50, and 100 μg/kg) were injected in accordance with surgical needs every 45 min. BChE was measured 3 min after injection by an automatic colorimetric method. Results: BChE decreased significantly in all except one patient in comparison to the baseline (P<0.05). However all values remained within normal clinical range. A dose of 100 μg/kg yielded significant decrease in comparison to 10 μg/kg but not to other dosages. Linear regression was not significant for the dose-response relationship (P=0.05). Conclusion: After clinical incremental doses of pancuronium, BChE remained within clinical range.
AB - Introduction: Low-dose pancuronium is known to affect serum cholinesterase activity (BChE); however, the dose-response effect of clinical doses of pancuronium on BChE has not been investigated. Methods: Thirteen ASA I-II patients scheduled for elective surgery requiring muscle relaxation were enrolled in this study. All patients had normal BChE before surgery. Incremental doses of pancuronium (10, 20, 50, and 100 μg/kg) were injected in accordance with surgical needs every 45 min. BChE was measured 3 min after injection by an automatic colorimetric method. Results: BChE decreased significantly in all except one patient in comparison to the baseline (P<0.05). However all values remained within normal clinical range. A dose of 100 μg/kg yielded significant decrease in comparison to 10 μg/kg but not to other dosages. Linear regression was not significant for the dose-response relationship (P=0.05). Conclusion: After clinical incremental doses of pancuronium, BChE remained within clinical range.
KW - Butyrylcholinesterase
KW - Dose-response
KW - Pancuronium
UR - http://www.scopus.com/inward/record.url?scp=55349111795&partnerID=8YFLogxK
U2 - 10.1007/s00228-008-0548-9
DO - 10.1007/s00228-008-0548-9
M3 - Article
C2 - 18766333
AN - SCOPUS:55349111795
SN - 0031-6970
VL - 64
SP - 1043
EP - 1045
JO - European Journal of Clinical Pharmacology
JF - European Journal of Clinical Pharmacology
IS - 11
ER -